摘要
目的:研究虎杖苷与大黄素配伍对高尿酸血症(HUA)模型大鼠的保护作用,筛选两者最优配伍比例,并探讨其可能机制。方法:将SD大鼠随机分为正常对照组、模型组、苯溴马隆组(阳性对照,8 mg/kg)、虎杖苷单用组、大黄素单用组和两药合用A、B、C组,每组各剂量均设置5只大鼠。正常对照组和模型组大鼠均灌胃等体积0.3%羧甲基纤维素钠溶液,各给药组大鼠灌胃相应药物,灌胃体积均为0.1 m L/10 g,每日1次,连续7 d。除正常对照组外,其余各组大鼠均于末次给药1 h前单次腹腔注射氧嗪酸钾(300 mg/kg)以复制HUA模型。末次给药1 h后,检测正常对照组、模型组、苯溴马隆组以及虎杖苷单用组、大黄素单用组(剂量均分别为0.625、1.25、2.5、5、10 mg/kg)和合用A组[虎杖苷+大黄素剂量分别为(0.625+0.625)、(1.25+1.25)、(2.5+2.5)、(5+5)、(10+10)mg/kg]大鼠血清中尿酸的含量;利用中效原理计算上述单用组和合用组的效应(Fa)和联合指数(CI),绘制两成分单用及合用的量效关系曲线以及经模拟后的Fa-CI曲线,评价两药的合用效果。同法检测单用组和合用B、C组[虎杖苷+大黄素剂量分别为(0.625+0.625)、(0.625+1.25)、(0.625+2.5)、(0.625+5)、(0.625+10)mg/kg和(0.625+0.625)、(1.25+0.625)、(2.5+0.625)、(5+0.625)、(10+0.625)mg/kg]大鼠血清中尿酸的含量并计算Fa值,筛选两药的最佳配伍比例。检测正常对照组、模型组、苯溴马隆组以及虎杖苷、大黄素单用组(剂量均为10 mg/kg)和最佳配伍比例合用组大鼠血清中黄嘌呤氧化酶(XOD)的含量,初步分析其作用机制。结果:与正常对照组比较,模型组大鼠尿酸含量显著升高(P<0.01)。与模型组比较,除虎杖苷单用0.625 mg/kg组外,其余各给药组大鼠尿酸含量均显著降低(P<0.05或P<0.01)。两药单用及合用时,其Fa值均与药物剂量成正相关(截距>0,相关系数>0.9),且合用组的Fa值高于任一药物单用组;当模拟Fa值>15%时,其对应CI值<1,两药合用可表现出协同作用。当虎杖苷与大黄素的配伍比例为1∶4时,其Fa值(53.10)与合用A组(53.73)相当,且药物剂量更小[(0.625+2.5)mg/(kg·d)vs.(2.5+2.5)mg/(kg·d)]。与正常对照组比较,模型组大鼠血清XOD含量显著升高(P<0.01);与模型组比较,各给药组大鼠血清XOD含量均显著降低,且最佳比例配伍组显著低于虎杖苷、大黄素单用组(P<0.05或P<0.01)。结论:虎杖苷和大黄素单用或合用均可一定程度地通过抑制XOD的生成来降低HUA模型大鼠血清中尿酸的含量;两者具有一定的协同作用,其最佳配伍比例为1∶4。
OBJECTIVE:To study the protective effect of polydatin complicated with emodin on hyperuricemia(HUA)model rats,and to screen the optimal complication proportion and investigate the potential mechanism.METHODS:SD rats were randomly divided into normal control group,model group,benzbromarone group(positive control,8 mg/kg),polydatin alone group,emodin alone group and drug combination group A,B,C,with 5 rats in each group of each dosage.Normal control group and model group were given constant volume of 0.3%CMC-Na solution,administration groups were given relevant medicine intragastrically.Each group was given 0.1 m L/10 g intragastrically once a day,for consecutive 7 d.Expect for normal control group,other groups were given intraperitoneal injection of potassium oxonate 300 mg/kg 1 h before last medication to induce HUA model.One hour after last medication,the serum contents of uric acid(UA)were determined in normal control group,model group,benzbromarone group,polydatin/alone group(0.625,1.25,2.5,5,10 mg/kg)and drug combination group A[the dose of polydatin+emodin were(0.625+0.625),(1.25+1.25),(2.5+2.5),(5+5),(10+10)mg/kg].The effect(Fa)and combination index(CI)of above single drug groups and combination groups were calculated by the median effect principle.The dose-effect relationship curves of two components alone or combination were drawn;Fa-CI curves after simulation were also drawn to evaluate the effect of two-drug combination.Serum contents of UA in rats were determined and Fa value was calculated in single drug groups and drug combination group B,C[the dose of polydatin+emodin were(0.625+0.625),(0.625+1.25),(0.625+2.5),(0.625+5),(0.625+10)mg/kg and(0.625+0.625),(1.25+0.625),(2.5+0.625),(5+0.625),(10+0.625)mg/kg].The optimal complication proportion of two drugs were screened.The serum contents of xanthine oxidase(XOD)in rats were determined in normal control group,model group,benzbromarone group,polydatin/emodin alone group(10 mg/kg)and the optimal complication proportion groups.The mechanism was analyzed primarily.RESULTS:Compared with normal control group,the content of UA in model group was increased significantly(P<0.01).Compared with model group,except for 0.625 mg/kg polydatin alone group,the content of UA in other administration groups were decreased significantly(P<0.05 or P<0.01).When the two drugs were used alone or in combination,Fa value was positively correlated with drug dose(intercept>0,correlation coefficient>0.9),and Fa value of the combination group was higher than that of any single drug group;when the simulated Fa value was more than 15%,the corresponding CI value was less than 1,two-drug combination showed synergistic effect.When the complication proportion of polydatin and emodin was 1∶4,the Fa value(53.10)was similar to that of drug combination group A(53.73),and the dose of them were less[(0.625+2.5)mg/(kg·d)vs.(2.5+2.5)mg/(kg·d)].Compared with normal control group,serum content of XOD in model group was increased significantly(P<0.01);compared with model group,serum content of XOD in administration groups were decreased significantly,and the optimal complication proportion group was significantly lower than polydatin alone group and emodin alone group(P<0.05 or P<0.01).CONCLUSIONS:The polydatin and emodin used alone or in combination can reduce the serum content of UA in HUA model rats by inhibiting the generation of XOD.They have a certain synergistic effect,and the optimal complication proportion is 1∶4.
作者
张怡
杨馨悦
屈勇
陈运中
ZHANG Yi;YANG Xinyue;QU Yong;CHEN Yunzhong(School of Pharmacy,Hubei University of Traditional Chinese Medicine,Wuhan 430065,China;Dept.of Pharmacy,CR&WISCO General Hospital,Wuhan 430080,China)
出处
《中国药房》
CAS
北大核心
2020年第21期2603-2608,共6页
China Pharmacy
基金
国家重点研发计划中医药现代化研究重点专项(No.2017YFC1701003)。